Danielle Vanasse

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma”.

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-019-0737-3

N/A

0DataRank · unranked

317 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.008

N/A

0DataRank · unranked

101 citations

Melissa A. Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi +4 more

Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0864-x

N/A

0DataRank · unranked

4 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3012

N/A

0DataRank · unranked

4 citations

Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre +3 more